Who
Kevin Puylaert
Chief Sales Officer
Company insider
Files Form 4 as: Chief Sales Officer, SOPHiA GENETICS SA.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $11K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Mar 2026
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $1,491185 at $8.06 | filing |
| 5 Oct 2026filed 7 Oct 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $24631 at $7.92 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $693138 at $5.03 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $23647 at $5.03 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $15831 at $5.09 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $694138 at $5.03 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $23647 at $5.03 | filing |
| 6 Jul 2026filed 7 Jul 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $15831 at $5.09 | filing |
| 19 May 2026filed 20 May 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $15033 at $4.54 | filing |
| 19 May 2026filed 20 May 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $15033 at $4.54 | filing |
| 20 Apr 2026filed 21 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $16833 at $5.08 | filing |
| 20 Apr 2026filed 21 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $16833 at $5.08 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $2,663548 at $4.86 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $22446 at $4.86 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $14530 at $4.83 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $2,663548 at $4.86 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $22446 at $4.86 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $14530 at $4.83 | filing |
| 2 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Code A | —56,468 at $0.00 | filing |
| 2 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAoption or derivative · Payments & Processors | SEC FORM 4 Code A | —82,335 at $0.00 | filing |
News
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 5,000 Shares of Company StockSOPH · dailypolitical.com · 14 Oct 2026Critical Analysis: SOPHiA GENETICS (NASDAQ:SOPH) & Weave Communications (NYSE:WEAV)SOPH · themarketsdaily.com · 9 Oct 2026Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGISSOPH · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Kevin Puylaert; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.